mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.5 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.5 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.5 |